Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders-Reference-Cited by-同舟云学术

Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders

Published:2015-01-21 Issue:6 Volume:56 Page:1677-1685
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Vase Maja Ølholm,Maksten Eva Futtrup,Bendix Knud,Hamilton-Dutoit Stephen,Andersen Claus,Møller Michael Boe,Sørensen Søren Schwartz,Jespersen Bente,Kampmann Jan,Søndergård Esben,Nielsen Patricia Switten,D’amore Francesco

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.966242

Reference30 articles.

1. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

2. Therapeutic options in post-transplant lymphoproliferative disorders

3. U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

4. A Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory CD30-Positive Non-Hodgkin Lymphomas: Interim Results In Patients With DLBCL and Other B-Cell Lymphomas

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pathology Experience of Posttransplant Lymphoproliferative Disorder From One Tertiary Hospital: Pathology Concepts and Diagnostic Approach;Cureus;2024-02-18

2. How I treat posttransplant lymphoproliferative disorder;Blood;2023-10-26

3. The development of adult T cell leukemia/lymphoma in renal transplant recipients: report of two cases with literature review;Renal Replacement Therapy;2023-07-31

4. Post‐transplant lymphoproliferative disorder: Update on treatment and novel therapies;British Journal of Haematology;2023-03-22

5. Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder;Cancers;2022-12-01